Phase 3 Drug Trial for ALS Halted for Lack of Efficacy
The global CHAMPION-ALS trial of ravulizumab for adults with ALS is being discontinued following a data review, Alexion has announced. Medscape Medical News
Read More
- Environmentalist Reaches 45 Million Trees Over 4 Decades
- No Lasting Lung Damage After Full Recovery From COVID-19
